These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6356402)

  • 21. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indapamide sustained release: a review of its use in the treatment of hypertension.
    Robinson DM; Wellington K
    Drugs; 2006; 66(2):257-71. PubMed ID: 16451099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].
    Mallion JM; Asmar R; Ambrosioni E; MacMahon M; Coupez JM; de Cordoüe A; Barrandon S; Brault Y; Guez D; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():27-38. PubMed ID: 8952811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive action of indapamide. Comparative studies in several experimental models.
    Kyncl J; Oheim K; Seki T; Solles A
    Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
    Asmar R
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
    Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
    Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension.
    Hall WD; Weber MA; Ferdinand K; Flamenbaum W; Marbury T; Jain AK; Weidler D; Weiss R; Herron J; Codispoti J
    J Hum Hypertens; 1994 Aug; 8(8):571-5. PubMed ID: 7990083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and clinical pharmacology of indapamide.
    Caruso FS; Szabadi RR; Vukovich RA
    Am Heart J; 1983 Jul; 106(1 Pt 2):212-20. PubMed ID: 6869203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.
    Waeber B; Rotaru C; Feihl F
    Expert Opin Pharmacother; 2012 Jul; 13(10):1515-26. PubMed ID: 22725706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indapamide in hypertension: a study in general practice of new or previously poorly controlled patients.
    Wheeley MS; Bolton JC; Campbell DB
    Pharmatherapeutica; 1982; 3(2):143-52. PubMed ID: 7100225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of indapamide in hypertensive patients failing to respond to a beta-blocker alone.
    O'Boyle CP; Fitzgerald D; Kelly JG; O'Malley K; O'Brien ET
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):465-9. PubMed ID: 6492943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the antihypertensive effect of indapamide by indomethacin.
    Pasnani JS; Gulati OD; Hemavathi KG
    Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of 10 years of experience with indapamide as an antihypertensive agent.
    Thomas JR
    Hypertension; 1985; 7(6 Pt 2):II152-6. PubMed ID: 4077233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.